- Home
- BTBD vs NURO Comparison
BTBD vs NURO Comparison
Compare BTBD & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBD
- NURO
- Stock Information
- Founded
- BTBD 1987
- NURO 1996
- Country
- BTBD United States
- NURO United States
- Employees
- BTBD N/A
- NURO N/A
- Industry
- BTBD Restaurants
- NURO Medical/Dental Instruments
- Sector
- BTBD Consumer Discretionary
- NURO Health Care
- Exchange
- BTBD Nasdaq
- NURO Nasdaq
- Market Cap
- BTBD 9.8M
- NURO 8.2M
- IPO Year
- BTBD 2021
- NURO N/A
- Fundamental
- Price
- BTBD $1.58
- NURO $4.00
- Analyst Decision
- BTBD
- NURO
- Analyst Count
- BTBD 0
- NURO 0
- Target Price
- BTBD N/A
- NURO N/A
- AVG Volume (30 Days)
- BTBD 9.4K
- NURO 20.3K
- Earning Date
- BTBD 11-13-2024
- NURO 02-20-2025
- Dividend Yield
- BTBD N/A
- NURO N/A
- EPS Growth
- BTBD N/A
- NURO N/A
- EPS
- BTBD N/A
- NURO N/A
- Revenue
- BTBD $14,647,844.00
- NURO $3,767,764.00
- Revenue This Year
- BTBD N/A
- NURO N/A
- Revenue Next Year
- BTBD N/A
- NURO N/A
- P/E Ratio
- BTBD N/A
- NURO N/A
- Revenue Growth
- BTBD 4.20
- NURO N/A
- 52 Week Low
- BTBD $1.25
- NURO $2.66
- 52 Week High
- BTBD $2.32
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- BTBD 48.44
- NURO 50.59
- Support Level
- BTBD $1.46
- NURO $3.93
- Resistance Level
- BTBD $1.85
- NURO $4.11
- Average True Range (ATR)
- BTBD 0.11
- NURO 0.10
- MACD
- BTBD -0.00
- NURO 0.01
- Stochastic Oscillator
- BTBD 35.42
- NURO 51.85
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.